A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial – healthradar.net

A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial

AIdiscovered fibrosis Generative idiopathic inhibitor Phase pulmonary randomized TNIK Trial

Previous ArticleThe Mui Board will support mmWave sleep tracking and gesture control

Next Article Garmin has a new plan to improve your fitness using your food intake — if you pay for Connect+

Healthradar

Leave A Reply